What is a widely used neuromuscular training program designed to reduce ACL injury risk in athletes?

Get ready for your Physical Education, Philosophy, Adapted Activity and Sport Management Exam. Study with engaging quizzes and multiple choice questions, complete with helpful hints and detailed explanations. Boost your confidence and prepare to pass your exam!

Multiple Choice

What is a widely used neuromuscular training program designed to reduce ACL injury risk in athletes?

Explanation:
Neuromuscular training that targets how the body moves during dynamic tasks lowers ACL injury risk by improving knee alignment, balance, and strength. The FIFA 11+ neuromuscular training warm-up is widely used because it provides a structured, progressive sequence of drills—running, plyometrics, balance, and strength work—that specifically train safer movement patterns and knee control. When athletes regularly perform this 20–25 minute routine before activity, it enhances neuromuscular coordination and muscular support around the knee, reducing valgus stress and risky landings that contribute to ACL injuries. Other options described are general fitness programs or protocols not designed or validated for ACL injury prevention, so they don’t carry the same targeted effectiveness and widespread adoption.

Neuromuscular training that targets how the body moves during dynamic tasks lowers ACL injury risk by improving knee alignment, balance, and strength. The FIFA 11+ neuromuscular training warm-up is widely used because it provides a structured, progressive sequence of drills—running, plyometrics, balance, and strength work—that specifically train safer movement patterns and knee control. When athletes regularly perform this 20–25 minute routine before activity, it enhances neuromuscular coordination and muscular support around the knee, reducing valgus stress and risky landings that contribute to ACL injuries. Other options described are general fitness programs or protocols not designed or validated for ACL injury prevention, so they don’t carry the same targeted effectiveness and widespread adoption.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy